The effects of two new amphetamine-like derivatives on the phagocytic ability of the protozoan, Tetrahymena pyriformis

被引:0
作者
Alevisopoulos, G [1 ]
Stefanidou, M [1 ]
Pagou, M [1 ]
SiatraPapastaikoudi, T [1 ]
Koutselinis, A [1 ]
机构
[1] UNIV ATHENS,SCH PHARM,DIV PHARMACEUT CHEM,GR-11527 ATHENS,GREECE
来源
ATLA-ALTERNATIVES TO LABORATORY ANIMALS | 1997年 / 25卷 / 05期
关键词
amphetamines; haloperidol; lipophilicity; protozoan; Tetrahymena pyriformis;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Six new amphetamine-like molecules (2-[2,3-dihydro-4H-1,4-benzoxazine-4-yl]-1-methyl-2-[1-methyl-2-phenylethyiamino] ethanamines) were synthesised and their physicochemical behaviour was studied. The log P values (index of lipophilicity) of the derivatives were calculated according to Rekker's fragmental system. One derivative representative of each series (C-5508 and C-5512) was selected, and their biological effects on the phagocytic ability of the protozoan, Tetrahymena pyriformis, were studied as a basic functional test for an amphetamine-like action. Furthermore, the action of both derivatives when administered concomitantly with haloperidol was also investigated. The data indicate that both derivatives significantly increased the phagocytic ability of the protozoan (p < 0.001), presumably via an alternative pathway to that of one of the dopamine monoaminergic pools. The administration of haloperidol significantly suppressed phagocytosis (p < 0.001). However, cultures exposed to the derivatives and to haloperidol indicated quantitatively different reactions. The lipophilic behaviours of the derivatives provide a possible explanation for such distinct effects.
引用
收藏
页码:547 / 553
页数:7
相关论文
共 39 条
  • [1] AKBER SF, 1991, NUKLEARMED, V30, P294
  • [2] AMPHETAMINE PSYCHOSIS - BEHAVIORAL AND BIOCHEMICAL ASPECTS
    ANGRIST, B
    SATHANANTHAN, G
    WILK, S
    GERSHON, S
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1974, 11 : 13 - 23
  • [3] CLINICAL-PHARMACOLOGY AND PHARMACOKINETICS OF FLUOXETINE - A REVIEW
    BERGSTROM, RF
    LEMBERGER, L
    FARID, NA
    WOLEN, RL
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1988, 153 : 47 - 50
  • [4] CHRISTENSEN AV, 1981, BIOL PSYCHIAT, V16, P828
  • [5] Cuomo M J, 1994, J Am Coll Health, V42, P271
  • [6] DARVAS Z, 1990, ACTA MICROBIOL HUNG, V37, P285
  • [7] DAVIS JM, 1989, COMPREHENSIVE TXB PS, P1652
  • [8] PHARMACOKINETICS AND SIDE-EFFECTS OF PERFLUOROCARBON-BASED BLOOD SUBSTITUTES
    FLAIM, SF
    [J]. ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (04): : 1043 - 1054
  • [9] PROCESSING OF DIGESTIVE VACUOLES IN TETRAHYMENA AND THE EFFECTS OF DICHLOROISOPROTERENOL
    FOK, AK
    SHOCKLEY, BU
    [J]. JOURNAL OF PROTOZOOLOGY, 1985, 32 (01): : 6 - 9
  • [10] SELEGILINE AND PARKINSONS-DISEASE - PROTECTIVE AND SYMPTOMATIC CONSIDERATIONS
    GOLBE, LI
    LANGSTON, JW
    SHOULSON, I
    [J]. DRUGS, 1990, 39 (05) : 646 - 651